Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Deferasirox (360mg) Tablet
Therapeutic Category
Nephrology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Deferise 360 Tablet containing Deferasirox 360 mg is a clinically formulated iron chelation medicine aimed at controlling excess iron in patients requiring frequent blood transfusions. It helps reduce iron overload, protect vital organs, and maintain overall health in hematological disorders.
Deferasirox works by selectively binding to excess iron in the bloodstream and promoting its elimination via urine and feces. This mechanism helps maintain safe iron levels and prevents complications such as liver and cardiac damage.
The oral formulation offers convenient and reliable iron chelation therapy, enhancing patient compliance compared to more invasive alternatives. It ensures effective management of iron levels with consistent therapeutic outcomes.
With growing demand for iron chelation solutions and chronic hematology care, this tablet has strong potential in the market. Its clinical efficacy, steady prescription support, and increasing acceptance make it a valuable product for expanding reach and driving sustainable growth in the hematology segment.
Some patients may experience nausea, vomiting, diarrhea, abdominal discomfort, or skin rash. Rarely, serious side effects such as liver or kidney dysfunction, hearing or vision disturbances, or severe allergic reactions may occur and require immediate medical attention.
Deferise 360 Tablet is indicated for the treatment of chronic iron overload due to frequent blood transfusions in conditions such as thalassemia, sickle cell anemia, or other chronic anemias. It helps lower excessive iron levels, prevent organ damage, and maintain overall health in patients at risk of iron toxicity.
This medicine should be taken under strict medical supervision. Patients with liver or kidney impairment should consult their healthcare provider before use. Regular monitoring of iron levels, liver, and kidney function is recommended during therapy to ensure safety and effectiveness.
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children.
Composition : Atracurium (10mg) Injection
Composition : Thiocolchicoside (4mg) Capsule
Composition : Thiocolchicoside (4mg) Injection
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Chlorzoxazone (250mg) Tablet
Composition : Drotaverine (80mg) + Aceclofenac (100mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (4mg) Tablet
Composition : Aceclofenac (100mg) + Thiocolchicoside (8mg) Tablet
Composition : Baclofen (10mg) Tablet
Composition : Baclofen (20mg) Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Deferasirox 360mg Tablet has strong demand in the hematology and chronic care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in iron overload management, especially in patients undergoing repeated blood transfusions such as thalassemia and chronic anemia cases. It strengthens their hematology and specialty care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Deferasirox 360mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady chronic therapy demand, repeat prescriptions, and strong specialty-care market opportunities when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this hematology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.